These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26037881)

  • 1. Aripiprazole monotherapy can relieve ruminations in a case with nonpsychotic depression.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):E32-3. PubMed ID: 26037881
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of aripiprazole monotherapy in a patient presenting with delayed sleep phase syndrome associated with depressive symptoms.
    Suzuki H; Hibino H; Inoue Y; Mikami K
    Psychiatry Clin Neurosci; 2018 May; 72(5):375-376. PubMed ID: 29508475
    [No Abstract]   [Full Text] [Related]  

  • 3. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
    J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?
    Taylor WD
    JAMA Psychiatry; 2016 Apr; 73(4):319-20. PubMed ID: 26963364
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.
    Wisniewski SR; Chen CC; Kim E; Kan HJ; Guo Z; Carlson BX; Tran QV; Pikalov A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):965-72. PubMed ID: 19662630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential utility of aripiprazole monotherapy for the treatment of major depressive disorder comorbid with obsessive-compulsive disorder.
    Pae CU
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593. PubMed ID: 19659566
    [No Abstract]   [Full Text] [Related]  

  • 8. Aripiprazole monotherapy in a patient with major depressive disorder.
    Yokoyama Y; Kitamura H; Someya T
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1124-5. PubMed ID: 20398715
    [No Abstract]   [Full Text] [Related]  

  • 9. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.
    Arbaizar B; Dierssen-Sotos T; Gómez-Acebo I; Llorca J
    Gen Hosp Psychiatry; 2009; 31(5):478-83. PubMed ID: 19703642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of aripiprazole in the treatment of catatonia].
    Vörös V; Tényi T
    Neuropsychopharmacol Hung; 2010 Jun; 12(2):373-6. PubMed ID: 20606247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole as an adjunctive treatment for refractory major depression.
    Hellerstein DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1347-8. PubMed ID: 15588762
    [No Abstract]   [Full Text] [Related]  

  • 14. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
    Chen SJ; Hsiao YL; Shen TW; Chen ST
    J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole adjunctive to antidepressant therapy.
    Marcus RM; Sanchez R; Frost M; McQuade RD
    Am J Psychiatry; 2011 Feb; 168(2):211; author reply 211. PubMed ID: 21297051
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases.
    Uguz F; Sahingoz M
    Clin Neuropharmacol; 2014; 37(4):125-7. PubMed ID: 24992087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
    Dording C; Cassiello C; King F; Pencina M; Fava M; Mischoulon D
    Int Clin Psychopharmacol; 2013 Sep; 28(5):238-44. PubMed ID: 23764521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole treatment in a case of amphetamine-induced delusional infestation.
    Yeh TC; Lin YC; Chen LF; Chiang CP; Mao WC; Chang HA; Kao YC; Tzeng NS
    Aust N Z J Psychiatry; 2014 Jul; 48(7):681-2. PubMed ID: 24563196
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole for the treatment of depression in palliative care.
    Meyer-Junco LE
    J Palliat Med; 2015 Apr; 18(4):316. PubMed ID: 25714470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.